SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on August 22, 2014, reporting events occurring on August 20 and August 21, 2014. The filing addresses significant changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Departure of Director: Max E. Link, Ph.D., resigned as a member of the Board of Directors and Chairman of the Board effective August 20, 2014. He also stepped down as Chairman of the Nominating and Governance Committee.
- Reason for Departure: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Appointment of Chairman: B. Sonny Bal, M.D., a current Board member, was appointed as the new Chairman of the Board effective August 21, 2014.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. The only unusual item noted is the immediate resignation of the Chairman and a Board member.
Key Facts for Investor Verification
- Confirm the effective dates of Dr. Link's resignation and Dr. Bal's appointment.
- Verify the composition of the Board of Directors following these changes.
- Review subsequent filings to determine if Dr. Link's departure impacts the Nominating and Governance Committee's operations.